Why the study?
Does increased IGFBP-3 proteolysis in pregnancy serum increase IGF availability and stimulate DNA synthesis in cultured cells?
Population
Cultured chick embryo fibroblasts exposed to serum pools from healthy adults and women during late pregnancy
Comparison
Pregnancy serum vs Normal serum from healthy adults
Design
Preclinical
Authors
Loading...
Supports IGF bioavailability via IGFBP-3 proteolysis in pregnancy; hypothesis-generating for human cell-growth regulation.
Does increased IGFBP-3 proteolysis in pregnancy serum increase IGF availability and stimulate DNA synthesis in cultured cells?
In vivo proteolysis of IGFBP-3, as seen in pregnancy serum, increases the bioavailability of IGFs to target cells, enhancing biological activity such as DNA synthesis.
Blat et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: